CI Investments Inc
PACB icon

CI Investments Inc’s Pacific Biosciences PACB Stock Holding History

CI Investments Inc’s Portfolio PACB Stock Details PACB Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q4 		– Sell
-42,018
Closed -$71K – 1331
2024
Q3 		$71K Buy
42,018
+316
+0.8% +$519 ﹤0.01% 946
2024
Q2 		$57K Buy
41,702
+33,136
+387% +$66.9K ﹤0.01% 946
2024
Q1 		$32K Buy
8,566
+7
+0.1% +$41 ﹤0.01% 1069
2023
Q4 		$84K Buy
8,559
+642
+8% +$5.25K ﹤0.01% 874
2023
Q3 		$66K Sell
7,917
-236
-3% -$2.7K ﹤0.01% 910
2023
Q2 		$108K Sell
8,153
-773
-9% -$9.39K ﹤0.01% 773
2023
Q1 		$103K Sell
8,926
-115
-1% -$1.14K ﹤0.01% 736
2022
Q4 		$74K Buy
9,041
+6,468
+251% +$55.7K ﹤0.01% 828
2022
Q3 		$15K Sell
2,573
-192
-7% -$1.1K ﹤0.01% 1081
2022
Q2 		$12K Buy
2,765
+1,901
+220% +$11.6K ﹤0.01% 1030
2022
Q1 		$8K Buy
+864
New +$9.95K ﹤0.01% 1100

Other funds holding PACB

AIM
ARK Investment Management St. Petersburg, Florida $12.9B AUM 64.92% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
MA
Madrone Advisors Menlo Park, California $1.03B AUM 20.53% 1-Year Est. Return
EDRH
Edmond de Rothschild Holding Chambesy, Switzerland $6.91B AUM 19.7% 1-Year Est. Return
SoftBank Group
SoftBank Group Tokyo, Japan $11.4B AUM 27.91% 1-Year Est. Return
Millennium Management
Millennium Management New York $240B AUM 35.51% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Sumitomo Mitsui Trust Group
Sumitomo Mitsui Trust Group Minato-Ku, Tokyo, Japan $154B AUM 29.96% 1-Year Est. Return
NAMA
Nikko Asset Management Americas New York $7.07B AUM 50.91% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

CI Investments Inc's PACB Position: Q4 2024 in Review

CI Investments Inc sold out of Pacific Biosciences (PACB) in Q4 2024, closing a stake of 42,018 shares — an estimated $71K sold.

CI Investments Inc first reported a position in PACB in Q1 2022 and held it in 11 quarters. The position peaked at $108K in Q2 2023. 226 funds tracked by Wall St. Rank hold PACB as of Q4 2024.

  • CI Investments Inc reported no remaining Pacific Biosciences position as of Q4 2024 after selling out during the quarter.
  • CI Investments Inc sold 42,018 Pacific Biosciences shares in Q4 2024, an estimated $71K.
  • CI Investments Inc first reported a position in Pacific Biosciences in Q1 2022 and held it in 11 quarters.
  • CI Investments Inc's Pacific Biosciences position peaked at $108K in Q2 2023.
  • 226 funds tracked by Wall St. Rank held Pacific Biosciences as of Q4 2024.

Based on CI Investments Inc's 13F filing for Q4 2024, filed 12 Feb 2025.